PanTher Therapeutics2 days agoPanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations
EyeCool TherapeuticsSeptember 2, 2025EyeCool Therapeutics Appoints Dr. Vance Thompson to Board of Directors
